KALA BIO, Inc. (KALA) stock
KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.14−0.02 (-13.79%)
Close on Nov 13, 2026Market cap $2.68MP/E –Yield –
Kala Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Kala Bio's enterprise value was -$3.92M on Nov 11, 2026, against $14.50M a year earlier. Over the last 5 years it ranged from -$10.27M to $78.04M, with a median of $7.52M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.92M | -134.3% |
| 2025 | Dec 31, 2025 | $11.45M | -36.2% |
| 2024 | Dec 31, 2024 | $17.93M | – |
| 2023 | Dec 29, 2023 | -$3.33M | -107.2% |
| 2022 | Dec 30, 2022 | $46.58M | +42.3% |
| 2021 | Dec 31, 2021 | $32.74M | -88.8% |
| 2020 | Dec 31, 2020 | $292.95M | +190.5% |
| 2019 | Dec 31, 2019 | $100.85M | +54.2% |
| 2018 | Dec 31, 2018 | $65.39M | -81.2% |
| 2017 | Dec 29, 2017 | $347.88M | – |
See a number that looks wrong?